Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy. (2015)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2015-009566
PubMed Identifier: 26474943
Publication URI: http://europepmc.org/abstract/MED/26474943
Type: Journal Article/Review
Volume: 5
Parent Publication: BMJ open
Issue: 10
ISSN: 2044-6055